http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120122273-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120122273-A |
| titleOfInvention | Angiogenesis Promoters Containing Orexin-A Peptides |
| abstract | The present invention relates to an angiogenesis promoter containing orexin-A (orexin-A) as an active ingredient, and more specifically, orexin-A (orexin-A) induces angiogenesis and is associated with angiogenesis. It relates to a novel use of promoting angiogenesis by activating cell migration, infiltration and tube formation of cells. The present invention provides a pharmaceutical composition for the treatment of angiogenesis-dependent diseases containing orexin-A (orexin-A) as an active ingredient and orexin-A (orexin-A) as an active ingredient. The pharmaceutical composition containing orexin-A according to the present invention induces angiogenesis and thus, in the treatment of angiogenic diseases such as chronic ulcer, delayed wound healing, ischemic stroke, myocardial infarction, angina pectoris and cerebrovascular dementia. useful. |
| priorityDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.